Vas Narasimhan, chief executive officer of Novartis AG, reacts during... Fotografía de noticias - Getty Images
Performance slump takes toll on Novartis' CEO's 2022 payout
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
La EMA evalúa aprobar erenumab, de Novartis, en migraña
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Vasant Narasimhan | Novartis
Interview: Vas Narasimhan, the 'unboss' of Novartis
Watch CNBC's full interview with Novartis CEO Vas Narasimhan - YouTube
Novartis segrega Sandoz para crear un líder de los genéricos | Distribución y Consumo
Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager magazin
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook | Novartis,chief executive officer,Social
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Vas Narasimhan | One Young World
El CEO de Novartis advierte: una vacuna no bastará para combatir el COVID - Infobae
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Vas Narasimhan (@VasNarasimhan) / Twitter
El CEO de Novartis dice que el mundo está listo para el "estado de normalidad" - Salud News
Primer acuerdo mundial entre Novartis y el NHS
Vas Narasimhan (@VasNarasimhan) / Twitter
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Novartis chief criticises EU move to control pharma licensing in emergencies | Financial Times
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
The 'student' of leadership who seeks to inspire his employees | Financial Times
